@mondyinvest
The R&D spend is paltry because management just throw chips on a new board (ideally in 'partnership' with another minnow), shove them in a new box and rename them. I doubt there can be any significant R&D occurring at that spend.
Hell, BRN even include two of the original, old stock Akida chips in the Edge AI box (that is sold out, yet no customers have received their order...).
Given BRN's lack of commercial success, it could get worse with an underspend on future innovation.
Ann: Appendix 4D and 1H24 Financial Report, page-36
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.025(9.80%) |
Mkt cap ! $451.3M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.5¢ | 22.0¢ | $3.918M | 16.28M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 658476 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 112520 | 8 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| BRN (ASX) Chart |